|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Operating expenses: | |||||
| Cost of sales | |||||
| Selling and marketing | |||||
| Research and development | |||||
| General and administrative | |||||
| Depreciation and amortization | |||||
| Restructuring and related | |||||
| Total operating costs and expenses | |||||
| Loss from operations | |||||
| Other income (expense), net: | |||||
| Change in fair value of warrant liabilities | |||||
| Interest income (loss), net | |||||
| Change in fair value of contingent consideration | |||||
| Interest income, net | |||||
| Other expense, net | |||||
| Total other (loss) income, net | |||||
| Loss before income taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Net loss attributable to common stockholders per share: | |||||
| Basic (USD per share) | |||||
| Diluted (USD per share) | |||||
| Weighted average shares of common stock outstanding: | |||||
| Basic (shares) | |||||
| Diluted (shares) |
Loading...